Impact of three or four protease mutations at codons 33, 82, 84 and 90 on 2 week virological responses to tipranavir, lopinavir, amprenavir and saquinavir all boosted by ritonavir in Phase 2B trial BI 1182.51
ANTIVIRAL THERAPY（2004）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要